CBS 2019
CBSMD教育中心
中 文

双重抗血小板治疗持续时间

Abstract

Recommended Article

A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI Patient Selection and Clinical Outcomes in the STOPDAPT-2 Trial: An All-Comer Single-Center Registry During the Enrollment Period of the STOPDAPT-2 Randomized Controlled Trial Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial 6-Month Versus 12-Month Dual-Antiplatelet Therapy Following Long Everolimus-Eluting Stent Implantation: The IVUS-XPL Randomized Clinical Trial Safety of six-month dual antiplatelet therapy after second-generation drug-eluting stent implantation: OPTIMA-C Randomised Clinical Trial and OCT Substudy Cost-Effectiveness of Different Durations of Dual-Antiplatelet Use After Percutaneous Coronary Intervention Derivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel: The ABCD-GENE Score Clopidogrel Pharmacogenetics: State-of-the-Art Review and the TAILOR-PCI Study

Original Research2014 Oct;64(4):279-84.

JOURNAL:J Cardiol. Article Link

Serial intravascular ultrasound assessment of very late stent thrombosis after sirolimus-eluting stent placement

Yamanaga K, Tsujita K, Shimomura H et al. Keywords: Drug-eluting stent; Imaging; Intravascular ultrasound; Remodeling; Thrombosis

FULL TEXT PDF